RHYTHM PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.88 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-11-06
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.88M.
- 2024-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.01M.
- 2024-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $65.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $93.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2024-09-30 | $1.88M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.01M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $65.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $93.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $124.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $160.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $199.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $243.00K 10-K · filed 2023-03-01 |
| 2022-09-30 | $290.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $341.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $396.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $454.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $516.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $581.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $649.00K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $721.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $795.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $872.00K 10-Q · filed 2020-08-03 |
| 2020-03-31 | $952.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $1.03M 10-K · filed 2020-03-02 |
| 2019-09-30 | $1.12M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $1.21M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $1.29M 10-Q · filed 2019-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |